Vimarsana
Biggest News Aggregation in the World

Page 6 - Linical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Studies Today - Breaking & Trending Today

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript - Vimarsana News

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript March 28, 2024 ENDRA Life Sciences Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.36. NDRA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]

Source: yahoo.com
Ultraprocessed Food Increases Disease Burden in UC - Vimarsana News

Ultraprocessed Food Increases Disease Burden in UC

Dietary strategies for patients with ulcerative colitis should focus on boosting the consumption of unprocessed or minimally processed foods.

Later Hernia Repair in Preterm Infants Reduces Risks - Vimarsana News

Later Hernia Repair in Preterm Infants Reduces Risks

A new study suggests that delaying inguinal hernia repair in preterm infants until after NICU discharge results in better outcomes compared with performing repair procedures before discharge.

Black Women More Likely to Die From Endometrial Cancer - Vimarsana News

Black Women More Likely to Die From Endometrial Cancer

New research confirms racial disparities in survival outcomes and representation in clinical trials among Black and White women with a common subtype of endometrial cancer.

Acadia to Stop Trials Of Antipsychotic Drug After It Fails Schizophrenia Study - Vimarsana News

Acadia to Stop Trials Of Antipsychotic Drug After It Fails Schizophrenia Study

Acadia Pharmaceuticals said on Monday it does not plan to conduct further clinical trials of its antipsychotic drug, pimavanserin, after it failed to improve negative...